VEGFA and neoplasm: STK11 affects tumor cell growth through various important cellular pathways, and gene mutations can affect pathways such as AMPK, STING, and vascular endothelial growth factor, leading to immune suppression and changes in the metabolic environment, which resulted in tumor growth (10).